Abstract: The present invention relates to compounds useful for treating disorders associated with abnormal blood glucose levels in mammals, such as Type I and Type II diabetes. The invention also relates to methods of making and using such compounds.
Type:
Grant
Filed:
September 26, 2001
Date of Patent:
March 23, 2004
Assignee:
Medical Research Counsel
Inventors:
Patricia Townsend Wade Cohen, Christopher George Armstrong, Martin John Doherty